A lung perfusion scan is a specialized imaging procedure designed to evaluate blood flow within the pulmonary vasculature, providing critical information for the diagnosis and management of various respiratory and cardiovascular conditions. By visualizing areas of reduced or absent perfusion, clinicians can identify pulmonary embolism, chronic thromboembolic pulmonary hypertension, and other vascular abnormalities. The technique is often combined with a ventilation scan to create a ventilation-perfusion (V/Q) study, which distinguishes perfusion defects caused by vascular obstruction from those related to airway disease.
During a lung perfusion scan, a radiopharmaceutical agent is injected intravenously, traveling through the pulmonary circulation. Gamma cameras detect the distribution of the tracer, producing detailed images that highlight areas of diminished blood flow. Interpretation focuses on patterns of perfusion loss, which may be segmental or subsegmental, aiding in risk stratification and treatment planning. This non-invasive method is particularly valuable for patients with contraindications to contrast-enhanced computed tomography, such as those with renal impairment or contrast allergies. The clinical utility of lung perfusion scanning extends beyond diagnosis. It can guide anticoagulation therapy, monitor disease progression, and assess postoperative outcomes in patients undergoing pulmonary thromboendarterectomy or other vascular interventions. Advances in imaging software and hybrid techniques, including SPECT/CT, are enhancing spatial resolution and diagnostic accuracy. By combining physiological assessment with high-resolution imaging, lung perfusion scans provide a precise evaluation of pulmonary blood flow, informing tailored management strategies and improving clinical decision-making in vascular and respiratory disorders.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation